Blue Earth Therapeutics Begins Phase 1 Trial for Innovative Prostate Cancer Treatment#London#United_Kingdom#Clinical_Trial#Prostate_Cancer#Blue_Earth
Blue Earth Therapeutics Begins Phase 1 Trial for Innovative Prostate Cancer Treatment
Blue Earth Therapeutics, in partnership with UCL, expands cancer treatment options by initiating a Phase 1 trial for Actinium-based therapy in prostate cancer patients.
third-news.com
July 9, 2026 at 10:08 AM
Blue Earth Therapeutics Begins Phase 1 Trial for Innovative Prostate Cancer Treatment#London#United_Kingdom#Clinical_Trial#Prostate_Cancer#Blue_Earth
Blue Earth Therapeutics Unveils Promising Phase 1 Results for Prostate Cancer Treatment#United_Kingdom#Oxford#Prostate_Cancer#Blue_Earth#Lutetium
Blue Earth Therapeutics Unveils Promising Phase 1 Results for Prostate Cancer Treatment
Blue Earth Therapeutics presents significant findings from its Phase 1 clinical trial of Lutetium (177Lu) rhPSMA-10.1 Injection, showcasing hope for prostate cancer patients.
third-news.com
June 25, 2025 at 7:09 AM
Blue Earth Therapeutics Unveils Promising Phase 1 Results for Prostate Cancer Treatment#United_Kingdom#Oxford#Prostate_Cancer#Blue_Earth#Lutetium